Table 2.
Not pregnant | Pregnant | |||||||
---|---|---|---|---|---|---|---|---|
15–24 | 25–49 | 15–24 | 25–49 | |||||
Year | Number of seroconversion (PY) | HIV incidence (95% CI) | Number of seroconversion (PY) | HIV incidence (95% CI) | Number of seroconversion (PY) | HIV incidence (95% CI) | Number of seroconversion(PY) | HIV incidence (95% CI) |
2010 | 105 (2089.16) | 5.03 (4.15–6.09) | 44 (2147.42) | 2.05 (1.52–2.75) | 11 (255.69) | 4.30 (2.38–7.77) | 0 (121.62) | 0 |
2011 | 70 (1374.23) | 5.09 (4.03–6.44) | 51 (1813.90) | 2.81 (2.14–3.70) | 15 (178.99) | 8.38 (5.05–13.90) | 1 (109.56) | 0.91 (0.13–6.48) |
2012 | 57 (971.10) | 5.87 (4.53 -7.61) | 50 (1624.24) | 3.08 (2.33–4.06) | 6 (141.48) | 4.24 (1.91 - 9.44) | 1 (101.96) | 0.98 (0.14–6.96) |
2013 | 43 (641.05) | 6.71 (4.97–9.04) | 50 (1381.22) | 3.62 (2.74–4.78) | 12 (98.4) | 12.20 (6.93–21.47) | 2 (77.31) | 2.59 (0.65–10.34) |
2014 | 37 (400.34) | 9.24 (6.70–12.76) | 36 (1131.51) | 3.18 (2.29–4.41) | 3 (51.78) | 5.79 (1.87–17.96) | 2 (70.20) | 2.85 (0.71–11.39) |
2015a | 16 (134.70) | 11.88 (7.28–19.39) | 7 (510.57) | 1.37 (0.65–2.88) | 2 (8.12) | 24.63 (6.16–98.48) | 0 (14.62) | 0 |
a Some pregnancies in the later part of 2015 would be reported in the first surveillance round in 2016 when women disclose their pregnancy to the household or attend antenatal care; hence 2015 may not include all women who were pregnant in 2015